DDX41 and influenza: The single-domain VL Abs, NVLM10, and its engineered bivalent molecule, NVL2M10, exhibited neutralization activity against H1N1/PR8 with plaque and viral protein, viral genome expression reductions in vitro by binding to influenza virions.